Moderna Inc. Secures Positive CHMP Opinion for First Flu Covid Combination Vaccine
Moderna Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation for mCOMBRIAX (mRNA-1083) in the European Union.
Positive CHMP Opinion | 04/03/2026 | By Darshana | 134
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy